Premium
Unique roles of phosphorus in endochondral bone formation and osteocyte maturation
Author(s) -
Zhang Rong,
Lu Yongbo,
Ye Ling,
Yuan Baozhi,
Yu Shibin,
Qin Chunlin,
Xie Yixia,
Gao Tian,
Drezner Marc K,
Bonewald Lynda F,
Feng Jian Q
Publication year - 2011
Publication title -
journal of bone and mineral research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.882
H-Index - 241
eISSN - 1523-4681
pISSN - 0884-0431
DOI - 10.1002/jbmr.294
Subject(s) - osteocyte , endochondral ossification , fibroblast growth factor 23 , osteoclast , osteoblast , endocrinology , bone remodeling , dmp1 , rankl , medicine , microbiology and biotechnology , hypophosphatemia , phex , chemistry , intramembranous ossification , biology , calcium , anatomy , immunology , rickets , parathyroid hormone , activator (genetics) , cartilage , vitamin d and neurology , biochemistry , receptor , viral matrix protein , virus , in vitro
The mechanisms by which inorganic phosphate (P i ) homeostasis controls bone biology are poorly understood. Here we used Dmp1 null mice, a hypophosphatemic rickets/osteomalacia model, combined with a metatarsal organ culture and an application of neutralizing fibroblast growth factor 23 (FGF‐23) antibodies to gain insight into the roles of P i in bone biology. We showed (1) that abnormal bone remodeling in Dmp1 null mice is due to reduced osteoclast number, which is secondary to a reduced ratio of RANKL/OPG expressed by osteoclast supporting cells and (2) that osteoblast extracellular matrix mineralization, growth plate maturation, secondary ossification center formation, and osteoblast differentiation are phosphate‐dependent. Finally, a working hypothesis is proposed to explain how phosphate and DMP1 control osteocyte maturation. © 2011 American Society for Bone and Mineral Research.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom